ABSIEVE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Feb 2025)
What this means for you
Registered since 15 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86970797
- Registration number
- 5263476
- Mark type
- Stylized text
- Filed
- 11 Apr 2016
- Published for opposition
- 30 May 2017
- Registered
- 15 Aug 2017
- Attorney of record
- Karen L. Elbing
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for identification and characterization of binding molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to antibody discovery, namely, scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to screening of antibody libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research and analysis in the field of antibody research and drug design
Owner
- AbCheck s.r.o., Plzen, CZ
- AbCheck s.r.o., Plzen, CZ
- AbCheck s.r.o., Plzen, CZ
Prior registrations
Prosecution history
- 12 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 26 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Feb 2024 — TEAS SECTION 8 & 15 RECEIVED
- 15 Aug 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 30 May 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 May 2017 — PUBLISHED FOR OPPOSITION
- 10 May 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Apr 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 17 Apr 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Apr 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Apr 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED